Serco Acquires QinetiQ's US Business for $292M, Targeting $370M Revenue by 2027

Veröffentlicht:

Datenübersicht

Deal Consideration
$292M total ($237M operating + $55M tax benefit)
Implied Valuation Multiple
~9.9x 2027 EBIT (inc. synergies)
QinetiQ Shareholder Return
~£200M via additional buybacks
QinetiQ Non-Cash Impairment
~£175M
Forecast 2027 Revenue (QQUS)
~$370M
Expected Annual Synergies (by 2028)
≥$3M
Forecast 2027 Underlying Operating Profit
~$21M

Wichtige Erkenntnisse

  • •Serco pays $292M for QQUS ($237M operating business + $55M tax benefit), targeting $370M revenue and $21M underlying operating profit in 2027.
  • •The deal expands Serco's US annual revenue from ~$2B to nearly $2.5B, adding space, ISR, missile defence, and autonomous platform capabilities.
  • •QinetiQ plans to return ~£200M to shareholders via buybacks but will book a ~£175M non-cash impairment — cash-neutral but headline-negative.
  • •CFIUS regulatory clearance is the principal deal-risk catalyst to monitor before Q1 2027 completion.
  • •The transaction reinforces consolidation trends in US defence services but is unlikely to materially re-rate large-cap US defence majors like Lockheed Martin or Northrop Grumman.
The leverage map tracks Lockheed Martin Corporation (LMT), a stock, across eight candles. The displayed 24-hour open is $607.07, the close is $605.75, the high is $618.50, and the low is $600.59; the reported 24-hour change is −0.22%. The close is also the long-entry reference price: $605.75. Leverage tiers shown are 10×, 50×, and 800×. The chart summary does not provide liquidation prices, so none are stated. The pulse headline reports that Serco is acquiring QinetiQ’s U.S. business for $292 million and targets $370 million in revenue by 2027; those figures are headline context, not LMT price data. No related-market assets or percentage changes are supplied, so a cross-market leader or laggard cannot be identified.
LMT closed at $605.75, down 0.22% over 24 hours; the long-entry reference is $605.75, with 10×, 50×, and 800× leverage tiers.

As reported by multiple sources including Fidelity News and ADS Advance on 12 November 2026, Serco Inc. — the North American subsidiary of UK-listed Serco Group plc — has agreed to acquire QinetiQ Gro

Event Analysis

As reported by multiple sources including Fidelity News and ADS Advance on 12 November 2026, Serco Inc. — the North American subsidiary of UK-listed Serco Group plc — has agreed to acquire QinetiQ Group plc's United States division, known as QQUS, for total cash consideration of $292 million (approximately £218 million). The deal is structured as roughly $237 million for the operating business plus approximately $55 million attributable to acquired tax benefits, with expected cash-tax savings exceeding $100 million over 12 years. Completion is targeted for Q1 2027, pending US antitrust and foreign-investment (CFIUS) clearances.

Strategically, the transaction accelerates Serco's footprint in US national-security contracting. QQUS brings approximately 800 specialists with capabilities spanning space systems, ISR (intelligence, surveillance and reconnaissance), autonomous platforms, missile defence, naval systems, and satellite infrastructure — exactly the segments attracting elevated Pentagon and NATO procurement budgets. As reported by TechMarketView, Serco's US annual revenue is expected to rise from approximately $2 billion to nearly $2.5 billion, cementing its position as a credible large-cap US defence services player rather than a mid-tier challenger. This fits squarely within the broader defense and aerospace M&A and contract surge reshaping the sector.

For QinetiQ, the sale sharpens strategic focus on UK, European, and allied markets while returning approximately £200 million to shareholders via additional FY2028–FY2029 buybacks. The trade-off is a non-cash impairment of approximately £175 million — headline-ugly but cash-neutral, a distinction the market will need to price carefully. The deal is priced at approximately 9.9x implied 2027 EBIT (based on the $237M operating price against $21M forecast profit plus $3M synergies), a moderate multiple for a defence technology services asset in the current environment.

What This Means for Traders

The clearest near-term trade is a classic acquisition-repricing dynamic: Serco shares face execution and integration risk on a material step-up deal, while QinetiQ shares benefit from capital-return optionality and a sharper strategic narrative — a pattern well-documented in acquisition-driven stock moves. The key catalysts to monitor are CFIUS clearance timing (a known source of deal uncertainty for UK-to-US defence transactions), delivery of the $21M profit forecast in 2027, and QinetiQ's shareholder return programme timing.

Broadly, the deal reinforces the M&A acquisition wave in defence services. US-listed defence majors like Lockheed Martin and Northrop Grumman are unlikely to be directly repriced by this transaction — the deal is too small to shift sector multiples — but it does signal continued consolidation pressure in US defence IT and mission-support, which is a constructive read-through for the sub-sector. Volatility on Serco and QinetiQ shares could be elevated around any CFIUS update or Q1 2027 completion confirmation.

This event is predominantly a UK-listed equity story (Serco Group plc trades on the London Stock Exchange). Traders should note that most London-listed stock CFDs follow exchange hours and are not available 24/7 — check instrument-specific trading hours on CoinUnited.io before positioning.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices and commodities from one crypto-funded account. Leverage up to 2000x on selected products, subject to eligibility; fees are tiered by 30-day volume.

Häufig gestellte Fragen

CFIUS (Committee on Foreign Investment in the United States) review is the primary regulatory hurdle for a UK-to-US defence asset transfer; delays or conditional approvals are the most likely deal-risk scenarios.

Haftungsausschluss: Dieser Brief dient nur zu Bildungszwecken und ist keine Anlageberatung.